KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P33
Within normal range
vs 2Y Ago
-8.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-7.27%
2024-3.30%
20230.89%
2022-44.21%
2021-42.07%
2020-18.84%
20199.80%
201820.31%
201720.00%
201661.10%